IP Library Granted Patent US 12,653,568
Granted Patent B2
US 12,653,568 · App. 17/909,028 · Granted Jun 16, 2026

Ultrasonic probes for producing multiple cavitation volumes

Inventor: Frederick Jay Bennett (Bellevue, WA)
Assignee: Solta Medical Ireland Limited
A61B17/320068A61B2017/00792A61B17/22004A61B2017/22008A61B2017/320073A61B2017/320089
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,653,568
App. No.
17/909,028
Granted
Jun 16, 2026
Kind
B2
Abstract

Probes for delivering ultrasonic energy and related methods. The probe includes a shank having a shaft coupling a proximal end to a distal end. The shank is configured to propagate ultrasonic energy from the proximal end to a tip of the distal end in a propagation direction parallel to a longitudinal axis disposed along a centerline of the shank. The tip may be positioned to substantially coincide with a displacement antinode position when the ultrasonic energy corresponds to odd integer multiples of a quarter wavelength of a resonance frequency. Multiple grooves within the shaft are configured to create multiple cavitation volumes in a medium proximate to the shank responsive to the ultrasonic energy. The multiple grooves include a second groove intervening between a first groove and the proximal end. The first groove is positioned at a distance of an integer multiple of a half-wavelength of the resonance frequency.

Claims (15)

1 . A probe comprising:

a shank including a proximal end, a distal end, and a shaft extending from the proximal end to the distal end, the proximal end of the shank configured to be coupled to a source of ultrasonic energy, and the shank being configured to propagate the ultrasonic energy from the proximal end to a tip at the distal end in a propagation direction parallel to a longitudinal axis of the shank;

a first groove within the shaft, the first groove positioned proximate to the tip; and

a second groove within the shaft, the second groove positioned along the shank between the first groove and the proximal end,

wherein the shaft includes a non-grooved section between the first groove and the second groove, the first groove is spaced from the second groove by a first distance approximately equal to a first integer multiple of a half-wavelength of a resonance frequency of the shank in the propagation direction, and the first groove is located proximate to a first location at which the ultrasonic energy corresponds to a first odd integer multiple of a quarter wavelength of the resonance frequency.

2 . The probe of claim 1 wherein the tip is positioned relative to the proximal end to substantially coincide with a first displacement antinode position when the ultrasonic energy corresponds to an odd integer multiple of a quarter wavelength of the resonance frequency of the shank.

3 . The probe of claim 2 wherein the proximal end is configured to be coupled to the source of ultrasonic energy at a point that substantially coincides with a second displacement node position when the ultrasonic energy corresponds to the odd integer multiple of the quarter wavelength of the resonance frequency of the shank.

4 . The probe of claim 1 wherein the second groove is located proximate to a second location at which the ultrasonic energy corresponds to a second odd integer multiple of a quarter wavelength of the resonance frequency.

5 . The probe of claim 1 wherein the first groove is included in a first plurality of grooves, and the second groove is included in a second plurality of grooves.

6 . The probe of claim 4 wherein the shank in the non-grooved section has an outer surface with a first diameter, and the shaft at a first position of each of the first plurality of grooves has a second diameter that is less than the first diameter.

7 . The probe of claim 6 wherein the shaft at a second position of each of the second plurality of grooves has a third diameter that is less than the first diameter, and the second diameter is equal to the third diameter.

8 . The probe of claim 5 wherein the shaft has an outer surface with a first diameter, the shaft includes a plurality of flanges that project from the outer surface, each of the first plurality of grooves is positioned between an adjacent pair of the plurality of flanges, and the shaft at a position of each of the first plurality of grooves has a second diameter that is equal to the first diameter.

9 . The probe of claim 1 wherein the shaft further includes a third groove intervening between the second groove and the proximal end, and the first groove is spaced from the third groove by a second distance approximately equal to a second integer multiple of a half-wavelength of the resonance frequency of the shank in the propagation direction.

10 . The probe of claim 1 wherein the shank includes a lumen extending from the distal end to the proximal end, and the tip includes a port coupled to the lumen.

11 . The probe of claim 10 wherein the lumen is configured to be coupled to an external source of suction.

Assignments (8)
U.S. PATENT SECURITY AGREEMENT Recorded Nov 25, 2025
From: SOLTA MEDICAL IRELAND LIMITED
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 073715/0394 →
RELEASE OF SECURITY INTEREST Recorded Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD; SANTARUS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; HUMAX PHARMACEUTICAL S.A.; SOLTA MEDICAL IRELAND LIMITED; BAUSCH & LOMB MEXICO, S.A. DE C.V.; BAUSCH+LOMB OPS B.V.; BAUSCH HEALTH AMERICAS, INC.; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH HOLDCO LIMITED; BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC); BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA); BAUSCH HEALTH US, LLC; BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.; ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.); ORAPHARMA, INC.; PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.); SOLTA MEDICAL DUTCH HOLDINGS B.V.; V-BAC HOLDING CORP.; VRX HOLDCO LLC; 1261229 B.C. LTD.; 1530065 B.C. LTD.
Reel/Frame 070778/0199 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jun 9, 2023
From: BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.; SALIX PHARMACEUTICALS, INC.; SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 063942/0001 →
CONFIRMATORY PATENTS ASSIGNMENT Recorded Jan 11, 2023
From: BAUSCH HEALTH IRELAND LIMITED
To: SOLTA MEDICAL IRELAND LIMITED
Reel/Frame 062352/0396 →
SECURITY AGREEMENT (FIRST LIEN) Recorded Nov 4, 2022
From: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061882/0708 →
SECURITY AGREEMENT (SECOND LIEN) Recorded Nov 4, 2022
From: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 062078/0276 →
SECURITY AGREEMENT (SECOND LIEN) Recorded Oct 5, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061606/0468 →
SECURITY AGREEMENT (FIRST LIEN) Recorded Oct 4, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061595/0066 →
Continuity (2)
Provisional Application 62991142 · Mar 18, 2020
Related Publication 20230087566A1 · Mar 23, 2023
References Cited (35)
US 5205817A · Idemoto · 1993 [cited by examiner]
US 5879364A · Bromfield · 1999 [cited by examiner]
US 6368299B1 · Cimino · 2002 [cited by examiner]
US 9114245B2 · Dietz et al. · 2015 [cited by applicant]
US 9333005B2 · Schafer · 2016 [cited by examiner]
US 11583306B2 · Olson et al. · 2023 [cited by applicant]
US 11602770B2 · Akagane · 2023 [cited by applicant]
US 20080194999A1 · Yamaha et al. · 2008 [cited by applicant]
US 20100168741A1 · Sanai et al. · 2010 [cited by applicant]
US 20110313345A1 · Schafer · 2011 [cited by applicant]
US 20160100982A1 · McCary · 2016 [cited by applicant]
CN 104582605A · 2015 [cited by applicant]
CN 107072813A · 2017 [cited by applicant]
EP 2796170A1 · 2014 [cited by applicant]
JP S63302842A · 1988 [cited by applicant]
JP 2008521547A · 2008 [cited by applicant]
JP 2013501599A · 2013 [cited by applicant]
JP 2013530739A · 2013 [cited by applicant]
WO 9944514A1 · 1999 [cited by applicant]
WO 2010076873A1 · 2010 [cited by applicant]
WO 2017119099A1 · 2017 [cited by applicant]
Taiwan Intellectual Property Office, Examination Report issued in Taiwanese Patent Application No. 110109143 on Jun. 4, 2024; 18 pages. [cited by applicant]
Japanese Patent Office, Notice of Allowance issued in Japanese Patent Application No. 2022-555775 on Aug. 4, 2025; 2 pages. [cited by applicant]
China National Intellectual Property Administration, Notification of Allowance issued in Chinese Patent Application No. 202180021913X on Mar. 18, 2025; 4 pages. [cited by applicant]
European Patent Office, Communication under Rule 71(3) EPC, Intention to Grant, issued in European Patent Application No. 21712978.2 on Jul. 17, 2025; 6 pages. [cited by applicant]
IP Australia, Australian Patent Office, Examination Report No. 1 issued in Australian Patent Application No. 2021237684 on Nov. 6, 2025; 4 pages. [cited by applicant]
Taiwan Intellectual Property Office, Rejection Decision issued in Taiwanese Patent Application No. 110109143 on Jan. 8, 2025; 6 pages. [cited by applicant]
Ministry of Intellectual Property of South Korea, Notice of Preliminary Rejection issued in Korean Patent Application No. 10-2022-7035589 on Sep. 26, 2025; 24 pages. [cited by applicant]
European Patent Office, Communication pursuant to Article 94(3) EPC issued in European Patent Application No. 21712978.2 on Jun. 5, 2024; 5 pages. [cited by applicant]
European Patent Office, International Search Report and Written Opinion issued in International Patent Application No. PCT/EP2021/056490, 15 pages (Jun. 17, 2021). [cited by applicant]
Japan Patent Office, Notice of Reasons for Rejection issued in Japanese Patent Application No. 2022-555775 on Apr. 2, 2025; 6 pages. [cited by applicant]
Japan Patent Office, Notice of Reasons for Rejection issued in Japanese Patent Application No. 2022-555775 on Nov. 13, 2024; 12 pages. [cited by applicant]
Taiwan Intellectual Property Office, Allowance Decision issued in Taiwanese Patent Application No. 110109143 on May 20, 2025; 3 pages. [cited by applicant]
China National Intellectual Property Administration, First Office Action and Search Report issued in Chinese Patent Application No. 202180021913.X on Sep. 30, 2024; 18 pages. [cited by applicant]
IP Australia, Australian Patent Office, Notice of Acceptance for Patent Application issued in Australian Patent Application No. 2021237684 on Jan. 7, 2026; 3 pages. [cited by applicant]